A featured article in the British Medical Journal relates the perspective of FDA investigator Thomas Marciniak, who says “Drug companies have turned into marketing machines. They’ve kind of lost sight of the fact that they’re actually doing something which involves your health . . . You’ve got to take away the key components of the trials from drug companies.” 1 boring Old Man reflects further on the implications for psych drugs.
I think the worst is how psychiatric drug withdrawal reactions are systematically ignored in psychiatric drug research, its kind of an important thing to study I would think.
As you already know, psychiatric drug withdrawal reactions are pointed to by psychiatrists and drug companies as “relapse” and “prove” that the people experiencing the reactions are truly “sick.” What this gets is another and bigger dose of toxic drugs, often with new toxic drugs added into the cocktail.
All of this gives psychiatrists a chance to prescribe more and more drugs, which proves to them that they are truly doctors. So, they surely don’t want any studies done on anything like this and they don’t even believe in drug withdrawal from psych drugs.
And then you have the wonderful drug companies. They surely don’t want any studies done on this since it just might lead to lower profits for them and profit is all that they live for.
FDA History 1-10 (left side, scroll down) –